Pharmaceutical Executive-10-01-2009

Pharmaceutical Executive
Features

November 11, 2009

Seven Global Trends shaping the future of the pharmaceutical industry.

Pharmaceutical Executive
Features

November 04, 2009

As the first generation of biologics patents expire, companies are jokeying for position in follow-on biologics.

Pharmaceutical Executive
Features

October 02, 2009

How proper site activation and site enrollment can help you get the most from clinical trials.

Pharmaceutical Executive
Washington Report

October 01, 2009

All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.

Pharmaceutical Executive
From the Editor

October 01, 2009

Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.

Pharmaceutical Executive
Features

October 01, 2009

Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?

Back Page
Pharmaceutical Executive

October 01, 2009

The militant fringe of animal rights activists targets pharma.

Pharmaceutical Executive
Columns

October 01, 2009

Executives should embrace design to discover new markets and find new ways to server customers.

Pharmaceutical Executive
Columns

October 01, 2009

How a small competitor benefited from the use of interactive marketing.

Pharmaceutical Executive
Column

October 01, 2009

Leaders manage their time and focus their resources by limiting unwanted interruptions.

Pharmaceutical Executive
Column

October 01, 2009

Game-changers can create competitive advantages for pharmaceutical companies and products.